The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer

PURPOSE: Activation of the phosphatidylinositol 3-kinase (PI3K)/AKT/mTOR pathway has been implicated in anti-estrogen resistance in breast cancer. We tested the therapeutic potential of the novel PI3K/mTOR dual inhibitor P7170 in a panel of anti-estrogen-sensitive and -resistant models of ER+ breast...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Breast Cancer Res Treat
Main Authors: Bean, Jennifer R., Hosford, Sarah R., Symonds, Lynn K., Owens, Philip, Dillon, Lloye M., Yang, Wei, Shee, Kevin, Schwartz, Gary N., Marotti, Jonathan D., Muller, Kristen E., Rosenkranz, Kari M., Barth, Richard J., Chen, Vivian S., Agarwal, Veena R., Miller, Todd W.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2014
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4302040/
https://ncbi.nlm.nih.gov/pubmed/25491778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3201-6
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla